"Pharma R&D set to endure despite rising MFN costs" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

The number of “innovation champions” in the pharma industry working on infectious diseases is dropping — and that’s troubling ...

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

The deal on drug prices between the US Administration and Pfizer will leave the margins of innovative pharma companies intact ...

In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.